Chromobox 2 Expression Predicts Prognosis After Curative Resection of Oesophageal Squamous Cell Carcinoma
Conclusion: CBX2 overexpression in OSCC tissues may serve as a novel biomarker for predicting survival and hematogenous recurrence.
Source: Cancer Genomics and Proteomics - Category: Cancer & Oncology Authors: UEDA, S., KANDA, M., SATO, Y., BABA, H., NAKAMURA, S., SAWAKI, K., SHIMIZU, D., MOTOYAMA, S., FUJII, T., KODERA, Y., NOMOTO, S. Tags: Article Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Esophagus Cancer | Skin Cancer | Squamous Cell Carcinoma